Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRigel Pharmaceuticals Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | $0.57 | $1.02 | $0.80 |
| Q2 2026 | 2 | $0.91 | $1.10 | $1.01 |
| Q3 2026 | 1 | $1.10 | $1.17 | $1.14 |
| Q4 2026 | 1 | $1.11 | $1.18 | $1.14 |
| Q1 2027 | 1 | $0.60 | $0.64 | $0.62 |
| Q2 2027 | 1 | $0.84 | $0.90 | $0.87 |
| Q3 2027 | 1 | $0.92 | $0.97 | $0.95 |
| Q4 2027 | 1 | $1.09 | $1.15 | $1.12 |
Rigel Pharmaceuticals Earnings Date And Information
Rigel Pharmaceuticals last posted its earnings results on Tuesday, May 5th, 2026. The company reported $0.44 earnings per share for the quarter, missing analysts' consensus estimates of $0.795 by $0.355. The company had revenue of 58.82 M for the quarter and had revenue of 294.28 M for the year. Rigel Pharmaceuticals has generated $20 earnings per share over the last year ($19.48 diluted earnings per share) and currently has a price-to-earnings ratio of 1.42. Rigel Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Rigel Pharmaceuticals Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/05/2026 | Q1 2026 | $0.80 | $0.47 | -0.33 | $62.40 M | $58.82 M |
| 03/03/2026 | Q4 2025 | $1.33 | $14.72 | 13.39 | $68.70 M | $69.80 M |
| 11/04/2025 | Q3 2025 | $0.93 | $1.55 | 0.62 | $61.88 M | $69.46 M |
| 08/05/2025 | Q2 2025 | $1.97 | $3.33 | 1.36 | $88.95 M | $101.69 M |
| 05/06/2025 | Q1 2025 | $0.14 | $0.64 | 0.5 | $43.87 M | $53.33 M |
| 03/04/2025 | Q4 2024 | $0.30 | $0.81 | 0.51 | $50.10 M | $57.60 M |
| 11/07/2024 | Q3 2024 | $0.06 | $0.71 | 0.65 | $41.94 M | $55.31 M |
| 08/06/2024 | Q2 2024 | -$0.37 | -$0.06 | 0.31 | $33.42 M | $36.84 M |
| 05/07/2024 | Q1 2024 | -$0.30 | -$0.47 | -0.17 | $31.47 M | $29.53 M |
| 03/05/2024 | Q4 2023 | $0.02 | $0.04 | 0.02 | N/A | $35.79 M |
| 11/07/2023 | Q3 2023 | -$0.70 | -$0.33 | 0.37 | N/A | $28.13 M |
| 08/01/2023 | Q2 2023 | -$0.80 | -$0.38 | 0.42 | N/A | $26.89 M |
| 05/02/2023 | Q1 2023 | -$0.90 | -$0.80 | 0.1 | N/A | $26.07 M |
| 03/07/2023 | Q4 2022 | -$0.70 | $0.10 | 0.8 | N/A | $51.28 M |
| 11/03/2022 | Q3 2022 | -$1.30 | -$1.10 | 0.2 | N/A | $22.41 M |
| 08/02/2022 | Q2 2022 | -$1.20 | -$0.80 | 0.4 | N/A | $29.82 M |
| 05/03/2022 | Q1 2022 | -$1.20 | -$1.60 | -0.4 | N/A | $16.74 M |
| 03/01/2022 | Q4 2021 | -$1.30 | -$1.30 | 0 | N/A | $20.41 M |
| 11/02/2021 | Q3 2021 | -$1.00 | -$1.20 | -0.2 | N/A | $21.54 M |
| 08/03/2021 | Q2 2021 | -$1.10 | -$0.80 | 0.3 | N/A | $26.27 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rigel Pharmaceuticals Earnings: FAQ's
The conference call for Rigel Pharmaceuticals's latest earnings report can be listened to online.
The conference call transcript for Rigel Pharmaceuticals's latest earnings report can be read online.
Rigel Pharmaceuticals (:RIGL) has a recorded annual revenue of $294.28 M.
Rigel Pharmaceuticals (:RIGL) has a recorded net income of $367.02 M.Rigel Pharmaceuticals has generated $20.4 earnings per share over the last four quarters.
Rigel Pharmaceuticals (:RIGL) has a price-to-earnings ratio of 1.42 and price/earnings-to-growth ratio is 0.